Sign in

CIK 0000730272

  • Large accelerated filer

REPLIGEN CORP

Sign in to watch
Ticker
RGEN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
042729386
Phone
+1 781-449-9560
Business address
41 SEYON STREET, BUILDING 1, SUITE 100, WALTHAM, MA, 02453
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$4,976,580
in 4 filings, $5.0M under 10b5-1 plans

Net −$4,976,580. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Loeillot Olivier −$5.0M Chief Executive Officer sold 37% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-03-04 Cox John Director Exercise or conversion · Stock Option (Right to Buy) −10,000 14,000
2020-03-04 Hunt Anthony Chief Executive Officer Sale −12,300 $90.13 $1.1M 230,241
2020-03-03 Snodgres Jon Chief Financial Officer Sale −610 $88.18 $54K 37,172
2020-03-03 RYAN THOMAS F JR Director Sale −2,225 $85.72 $191K 1,923
2020-03-03 KURIYEL RALF Senior VP, R&D Sale −450 $88.35 $40K 29,079
2020-03-03 Hunt Anthony Chief Executive Officer Sale −2,090 $88.20 $184K 242,641
2020-03-03 Hunt Anthony Chief Executive Officer Sale −100 $88.56 $9K 242,541
2020-03-01 Mhatre Rohin Director Grant or award · Stock Option (Right to Buy) +3,452 3,452
2020-02-27 Snodgres Jon Chief Financial Officer Grant or award +4,686 37,782
2020-02-27 Snodgres Jon Chief Financial Officer Grant or award · Stock Option (Right to Buy) −4,571 4,571
2020-02-27 Hunt Anthony Chief Executive Officer Grant or award +18,583 244,731
2020-02-27 Hunt Anthony Chief Executive Officer Grant or award · Stock Option (Right to Buy) −18,128 18,128
2020-02-27 KURIYEL RALF Senior VP, R&D Grant or award +3,216 29,529
2020-02-27 KURIYEL RALF Senior VP, R&D Grant or award · Stock Option (Right to Buy) +3,137 3,137
2020-02-26 Hunt Anthony Chief Executive Officer Sale −1,881 $86.86 $163K 227,742
2020-02-26 Hunt Anthony Chief Executive Officer Sale −1,594 $86.10 $137K 226,148
2020-02-26 Snodgres Jon Chief Financial Officer Sale −154 $86.86 $13K 32,042
2020-02-26 Snodgres Jon Chief Financial Officer Sale −946 $86.11 $81K 31,096
2020-02-26 KURIYEL RALF Senior VP, R&D Sale −195 $86.60 $17K 26,313
2020-02-25 Hunt Anthony Chief Executive Officer Exercise or conversion +11,735 $32.40 $380K 231,148

Page 39 of 42 · 832 trades